TACI-immunglobulinfusjonsproteiner, nukleinsyremolekyl som koder for dem, fremgangsmåte for fremstilling av dem, anvendelse derav, og farmasøytisk preparat som omfatter dem og et farmasøytisk aksepterbart bærestoff.

• 收藏
• 分享

专利权人:

ZymoGenetics Inc

发明人:

Gross, Jane A,Rixon, Mark W

申请号：

NO20035173

公开号：

NO337295B1

申请日:

2003.11.21

申请国别(地区):

NO

年份:

2016

代理人:

摘要：

Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/